ReviewSmart molecules : open access2026
Research on the degradation mechanism, product effects and optimization strategy of the tributyl phosphate solvent system in the PUREX process.
Review in Smart molecules : open access, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While nuclear energy represents a low-carbon and high-efficiency energy source that plays a vital role in the global energy mix, the limitations of spent fuel reprocessing technology pose a major challenge to its sustainable development. The PUREX (plutonium uranium redox extraction) process is currently the dominant nuclear fuel reprocessing technology in the world. However, the key extractant in this process is tributyl phosphate (TBP), which degrades under intense radiation, high temperatures, and strong acidity. This leads to the production of dibutyl phosphate, monobutyl phosphate, and other degradation byproducts, which may reduce the extraction efficiency and trigger third-phase formation and equipment corrosion. This paper systematically reviews the degradation mechanisms of TBP and its diluents, the analytical technique suitable for characterizing degradation products, and the impact of degradation products on the post-treatment process. Additionally, optimization strategies employed for suppressing third-phase formation are discussed. This study offers a theoretical foundation and technical insights in optimizing the PUREX process and ensuring the safe operation of the post-treatment process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.